This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallari, A. S.
Right arrow Articles by Devare, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallari, A. S.
Right arrow Articles by Devare, S. G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 1998, p. 3657-3661, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Rapid Assay for Simultaneous Detection and Differentiation of Immunoglobulin G Antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2

Ana S. Vallari,* Robert K. Hickman, John R. Hackett Jr., Catherine A. Brennan, Vincent A. Varitek Jr., and Sushil G. Devare

AIDS Research and Retrovirus Discovery, Abbott Laboratories, North Chicago, Illinois, 60064-4000

Received 30 June 1998/Returned for modification 23 July 1998/Accepted 15 September 1998

A rapid immunodiagnostic test that detects and discriminates human immunodeficiency virus (HIV) infections on the basis of viral type, HIV type 1 (HIV-1) group M, HIV-1 group O, or HIV-2, was developed. The rapid assay for the detection of HIV (HIV rapid assay) was designed as an instrument-free chromatographic immunoassay that detects immunoglobulin G (IgG) antibodies to HIV. To assess the performance of the HIV rapid assay, 470 HIV-positive plasma samples were tested by PCR and/or Western blotting to confirm the genotype of the infecting virus. These samples were infected with strains that represented a wide variety of HIV strains including HIV-1 group M (subtypes A through G), HIV-1 group O, and HIV-2 (subtypes A and B). The results showed that the HIV genotype identity established by the rapid assay reliably (469 of 470 samples) correlates with the HIV genotype identity established by PCR or Western blotting. A total of 879 plasma samples were tested for IgG to HIV by a licensed enzyme immunoassay (EIA) (470 HIV-positive samples and 409 HIV-negative samples). When they were tested by the rapid assay, 469 samples were positive and 410 were negative (99.88% agreement). Twelve seroconversion panels were tested by both the rapid assay and a licensed EIA. For nine panels identical results were obtained by the two assays. For the remaining three panels, the rapid assay was positive one bleed later in comparison to the bleed at which the EIA was positive. One hundred three urine samples, including 93 urine samples from HIV-seropositive individuals and 10 urine samples from seronegative individuals, were tested by the rapid assay. Ninety-one of the ninety-three urine samples from HIV-seropositive individuals were found to be positive by the rapid assay. There were no false-positive results (98.05% agreement). Virus in all urine samples tested were typed as HIV-1 group M. These results suggest that a rapid assay based on the detection of IgG specific for selected transmembrane HIV antigens provides a simple and reliable test that is capable of distinguishing HIV infections on the basis of viral type.


* Corresponding author. Mailing address: Abbott Laboratories, Dept. 9 NG, 1401 Sheridan Rd., N. Chicago IL, 60064-4000. Phone: (847) 938-8931. Fax: (847) 937-1401. E-mail: ana.vallari{at}add.ssw.abbott.com.


Journal of Clinical Microbiology, December 1998, p. 3657-3661, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Gupta, A., Chaudhary, V. K. (2003). Whole-Blood Agglutination Assay for On-Site Detection of Human Immunodeficiency Virus Infection. J. Clin. Microbiol. 41: 2814-2821 [Abstract] [Full Text]  
  • Aidoo, S., Ampofo, W. K., Brandful, J. A. M., Nuvor, S. V., Ansah, J. K., Nii-Trebi, N., Barnor, J. S., Apeagyei, F., Sata, T., Ofori-Adjei, D., Ishikawa, K. (2001). Suitability of a Rapid Immunochromatographic Test for Detection of Antibodies to Human Immunodeficiency Virus in Ghana, West Africa. J. Clin. Microbiol. 39: 2572-2575 [Abstract] [Full Text]  
  • Peralta, L., Constantine, N., Griffin Deeds, B., Martin, L., Ghalib, K. (2001). Evaluation of Youth Preferences for Rapid and Innovative Human Immunodeficiency Virus Antibody Tests. Arch Pediatr Adolesc Med 155: 838-843 [Abstract] [Full Text]